Paradigm Biocapital Advisors LP Vor Biopharma Inc. Call Options Transaction History
Paradigm Biocapital Advisors LP
- $2.67 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VOR
# of Institutions
70Shares Held
29MCall Options Held
1.8KPut Options Held
100-
5 Am Venture Management, LLC San Francisco, CA6.36MShares$5.79 Million5.32% of portfolio
-
Laurion Capital Management LP New York, NY3.18MShares$2.9 Million0.07% of portfolio
-
Black Rock Inc. New York, NY2.25MShares$2.05 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.81MShares$1.65 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA1.11MShares$1.01 Million0.03% of portfolio
About Vor Biopharma Inc.
- Ticker VOR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,056,300
- Market Cap $34.6M
- Description
- Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...